Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

An Open Label, Two-way Crossover Study to Evaluate the PK Effects of Two Different Wafer Administration Protocols in Healthy Volunteers Under Fasted Conditions.

To see complete record on, please visit this link

Id: NCT02857361

Organisation Name: iX Biopharma Ltd.

Overal Status: Completed

Start Date: July 2016

Last Update: August 19, 2016

Lead Sponsor: iX Biopharma Ltd.

Brief Summary: The study will look at whether it is preferable to administer two wafers simultaneously or separately.

  • Pain

Total execution time in seconds: 0.1988730430603